Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidemiological cut-off values for Vibrio anguillarum MIC and disc diffusion data generated by standardised methods.
Smith P, Le Devendec L, Jouy E, Larvor E, Le Breton A, Picon-Camacho S, Zrnčić S, Zupičić IG, Oraić D, Karataş S, Verner-Jeffreys D, Joseph AW, Light E, Essen-Zandbergen AV, van Gelderen B, Voorbergen-Laarman M, Haenen OLM, Veldman KT, Madsen L, Mouritsen KK, Smith Svanevik C, Håkonsholm F, Vela AI, García M, Florio D, Fioravanti M, Cortinovis L, Pretto T, Manfrin A, Baron S. Smith P, et al. Among authors: le breton a. Dis Aquat Organ. 2023 Aug 31;155:109-123. doi: 10.3354/dao03745. Dis Aquat Organ. 2023. PMID: 37650482 Free article.
Draft Genome Sequences of Four Aeromonas salmonicida subsp. achromogenes Strains, 23051, 23053, 23055, and 23056, Isolated from Senegalese Sole (Solea senegalensis).
Vincent AT, Le Breton A, Bernatchez A, Gagné-Thivierge C, Paquet VE, Thibault E, Charette SJ, Gantelet H. Vincent AT, et al. Among authors: le breton a. Microbiol Resour Announc. 2019 Aug 15;8(33):e00631-19. doi: 10.1128/MRA.00631-19. Microbiol Resour Announc. 2019. PMID: 31416869 Free PMC article.
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
Zuily S, Lefèvre B, Sanchez O, Empis de Vendin O, de Ciancio G, Arlet JB, Khider L, Terriat B, Greigert H, Robert CS, Louis G, Trinh-Duc A, Rispal P, Accassat S, Thiery G, Montani D, Azarian R, Meneveau N, Soudet S, Le Mao R, Maurier F, Le Moing V, Quéré I, Yelnik CM, Lefebvre N, Martinot M, Delrue M, Benhamou Y, Parent F, Roy PM, Presles E, Goehringer F, Mismetti P, Bertoletti L, Rossignol P, Couturaud F, Wahl D, Thilly N, Laporte S; COVI-DOSE investigators. Zuily S, et al. EClinicalMedicine. 2023 Jun;60:102031. doi: 10.1016/j.eclinm.2023.102031. Epub 2023 Jun 9. EClinicalMedicine. 2023. PMID: 37350990 Free PMC article.
Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
Mercier N, Belhadi D, DeChanet A, Delmas C, Saillard J, Dumousseaux M, Le Mestre S, Fougerou-Leurent C, Ferrane A, Burdet C, Espérou H, Ader F, Hites M, Peiffer-Smadja N, Poissy J, Andrejak C, Paiva JA, Tacconelli E, Staub T, Greil R, Costagliola D, Mentre F, Yazdanpanah Y, Diallo A; DisCoVeRy Safety Working group. Mercier N, et al. Pharmacol Res Perspect. 2023 Jun;11(3):e01072. doi: 10.1002/prp2.1072. Pharmacol Res Perspect. 2023. PMID: 37269068 Free PMC article. Review.
21 results